StockWatch
·
Pharmaceuticals
Board Meeting10 Aug 2026, 07:11 pm

Auro Laboratories Ltd Board Meeting on Aug 14, 2026 for Unaudited Results

AI Summary

Auro Laboratories Ltd has announced that its Board of Directors will convene on August 14, 2026. The primary agenda item is to consider and approve the unaudited financial results for the quarter ended June 30, 2026, along with the limited review report. Additionally, the trading window for designated persons will remain closed until 48 hours after the board meeting concludes, in line with the company's insider trading code of conduct.

Key Highlights

  • Board meeting scheduled for August 14, 2026.
  • To approve unaudited financial results for Q1 FY27.
  • Limited review report to be considered.
  • Trading window closure extended post-meeting.